Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Revenue

Oryzon Genomics had revenue of 4.22M EUR in the quarter ending June 30, 2025, with 2.73% growth. This brings the company's revenue in the last twelve months to 7.47M, down -30.93% year-over-year. In the year 2024, Oryzon Genomics had annual revenue of 7.36M, down -48.15%.

• Revenue (ttm): 7.47M
• Revenue Growth: -30.93%
• P/S Ratio: 35.99
• Revenue / Employee: 158.96K
• Employees: 47
• Market Cap: 268.89M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.36M	-6.83M	-48.15%
Dec 31, 2023	14.19M	-1.51M	-9.60%
Dec 31, 2022	15.70M	5.08M	47.88%
Dec 31, 2021	10.62M	1.09M	11.49%
Dec 31, 2020	9.52M	-756.51K	-7.36%